RE:RE:No volumeBio, I hold the stock for the same reason as the rest of us. Because of the potential of its discovery platform.
However, managment continues to underperform badly and this has been the problem for 20 years now. New shareholders haven't caught on yet.
What needs to be done? Turf managment if they don't deliver this time on Ryplazim.